Insider Trading Summary for Amneal Pharmaceuticals, Inc. (AMRX): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
11-May-23 4:15 PM View:	10-May-23 Option Exercise 0	Buchi J Kevin Director		Amneal Pharmaceuticals, Inc. - AMRX	76% 105.49K to 185.62K	0	0	--	--	Show Txns Hide Txns

11-May-23 4:15 PM View:	10-May-23 Option Exercise 0	Alva Emily Peterson Director		Amneal Pharmaceuticals, Inc. - AMRX	85% 94.19K to 174.32K	0	0	--	--	Show Txns Hide Txns

11-May-23 4:15 PM View:	10-May-23 Option Exercise 0	Nark Ted C Director		Amneal Pharmaceuticals, Inc. - AMRX	56% 144.19K to 224.32K	0	0	--	--	Show Txns Hide Txns

08-Nov-23 6:22 PM View:	07-Nov-23 Acquisition (other) 0	Patel Tushar Bhikhubhai 10% Owner		Amneal Pharmaceuticals, Inc. - AMRX	100% 0 to 53.58M	0	0	--	--	Show Txns Hide Txns

11-May-23 4:15 PM View:	10-May-23 Option Exercise 0	Meister Paul M Director		Amneal Pharmaceuticals, Inc. - AMRX	22% 508.48K to 620.66K	0	0	--	--	Show Txns Hide Txns

11-May-23 4:15 PM View:	10-May-23 Option Exercise 0	Yanai Shlomo Director		Amneal Pharmaceuticals, Inc. - AMRX	90% 89.15K to 169.27K	0	0	--	--	Show Txns Hide Txns

11-May-23 4:15 PM View:	10-May-23 Option Exercise 0	Kiely John Director		Amneal Pharmaceuticals, Inc. - AMRX	81% 99.15K to 179.27K	0	0	--	--	Show Txns Hide Txns

11-May-23 4:15 PM View:	10-May-23 Option Exercise 0	George Jeffrey P. Director		Amneal Pharmaceuticals, Inc. - AMRX	71% 112.96K to 193.08K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:40 PM View:	03-Mar-24 Payment of Exercise ($243.75K)	Boyer Andrew S Executive Vice President		Amneal Pharmaceuticals, Inc. - AMRX	22% 262.52K to 319.38K	0	($120.92K) (11%)	--	$4.13	Show Txns Hide Txns

05-Mar-24 4:35 PM View:	03-Mar-24 Payment of Exercise ($225.01K)	Shah Nikita Executive Vice President		Amneal Pharmaceuticals, Inc. - AMRX	22% 319.97K to 391.67K	0	0	--	--	Show Txns Hide Txns

14-Mar-24 4:17 PM View:	12-Mar-24 Payment of Exercise ($163.50K)	Konidaris Tasos Executive Vice President & CFO		Amneal Pharmaceuticals, Inc. - AMRX	38% 380.84K to 527.32K	0	0	--	--	Show Txns Hide Txns

08-Nov-23 6:20 PM View:	07-Nov-23 Acquisition (other) 0	Patel Chintu Co-CEO Director		Amneal Pharmaceuticals, Inc. - AMRX	4830% 512.5K to 25.27M	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:54 PM View:	03-Mar-24 Payment of Exercise ($98.62K)	Daly Jason B. SVP, Chief Legal Officer		Amneal Pharmaceuticals, Inc. - AMRX	296% 14.48K to 57.32K	0	0	--	--	Show Txns Hide Txns

01-Aug-23 4:30 PM View:	30-Jul-23 Option Exercise 0	Autor Deborah M. Director		Amneal Pharmaceuticals, Inc. - AMRX	100% 0 to 54.95K	0	0	--	--	Show Txns Hide Txns

08-Nov-23 6:20 PM View:	07-Nov-23 Acquisition (other) 0	Patel Chirag K. President & Co-CEO Director		Amneal Pharmaceuticals, Inc. - AMRX	4149% 512.6K to 21.78M	0	0	--	--	Show Txns Hide Txns

08-Nov-23 6:21 PM View:	07-Nov-23 Acquisition (other) 0	Patel Dipan		Amneal Pharmaceuticals, Inc. - AMRX	100% 0 to 26.91M	0	0	--	--	Show Txns Hide Txns

03-Jan-24 4:36 PM View:	01-Jan-24 Disposition (other) 0	Patel Gautam Director		Amneal Pharmaceuticals, Inc. - AMRX	(85%) 13.18M to 1.97M	0	0	--	--	Show Txns Hide Txns

Amneal Pharmaceuticals, Inc. (AMRX)

Last Year

27-Apr-23 -- 26-Apr-24

Company Sentiment

Other

Other

Two Year Chart

27-Apr-22 -- 26-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	($120.92K)	$4.13